Cargando…
Against the Resilience of High-Grade Gliomas: Gene Therapies (Part II)
Introduction: High-grade gliomas (HGGs) still have a high rate of recurrence and lethality. Gene therapies were projected to overcome the therapeutic resilience of HGGs, due to the intrinsic genetic heterogenicity and immune evasion pathways. The present literature review strives to provide an updat...
Autores principales: | Giotta Lucifero, Alice, Luzzi, Sabino |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393930/ https://www.ncbi.nlm.nih.gov/pubmed/34439595 http://dx.doi.org/10.3390/brainsci11080976 |
Ejemplares similares
-
Against the Resilience of High-Grade Gliomas: The Immunotherapeutic Approach (Part I)
por: Giotta Lucifero, Alice, et al.
Publicado: (2021) -
Gene therapies for high-grade gliomas: from the bench to the bedside
por: Giotta Lucifero, Alice, et al.
Publicado: (2020) -
Potential roads for reaching the summit: an overview on target therapies for high-grade gliomas
por: Giotta Lucifero, Alice, et al.
Publicado: (2020) -
Immune Landscape in PTEN-Related Glioma Microenvironment: A Bioinformatic Analysis
por: Giotta Lucifero, Alice, et al.
Publicado: (2022) -
Microscope-based augmented reality with diffusion tensor imaging and fluorescein in insular glioma resection
por: Luzzi, Sabino, et al.
Publicado: (2022)